TP53 and breast carcinoma: In the present investigation, we tailored a panel of four TAAs, three of which (P53, MUC-1, and C-MYC) are the top among all breast cancer-associated tumor antigens used for detection of autoantibodies in terms of the frequency studies in addition to their close structural and function in BC.